These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Somatostatin receptors in non-neuroendocrine malignancies: the potential role of somatostatin analogs in solid tumors. Hasskarl J; Kaufmann M; Schmid HA Future Oncol; 2011 Jul; 7(7):895-913. PubMed ID: 21732759 [TBL] [Abstract][Full Text] [Related]
5. Somatostatin (second of two parts). Reichlin S N Engl J Med; 1983 Dec; 309(25):1556-63. PubMed ID: 6140639 [No Abstract] [Full Text] [Related]
7. The role of somatostatin and its analogs in the diagnosis and treatment of tumors. Lamberts SW; Krenning EP; Reubi JC Endocr Rev; 1991 Nov; 12(4):450-82. PubMed ID: 1684746 [No Abstract] [Full Text] [Related]
12. The use of somatostatin and its analogs in the treatment of surgical disorders. Mulvihill S; Pappas TN; Passaro E; Debas HT Surgery; 1986 Sep; 100(3):467-76. PubMed ID: 2874618 [TBL] [Abstract][Full Text] [Related]
14. Rationale for treating cancer with somatostatin analogs. Minuto F; Ferone D; Arvigo M; Barreca A J Endocrinol Invest; 2003; 26(8 Suppl):117-9. PubMed ID: 15233226 [No Abstract] [Full Text] [Related]
15. Therapeutic uses of somatostatin and its analogues: Current view and potential applications. Rai U; Thrimawithana TR; Valery C; Young SA Pharmacol Ther; 2015 Aug; 152():98-110. PubMed ID: 25956467 [TBL] [Abstract][Full Text] [Related]